Fiduciary assignment as a potential intervention for substance use disorder: a retrospective chart review

References

• Compensation: Service-Connected Disability or Death Benefits. U.S.D.o.V. Affairs, editor. USA: Veterans Benefits Administration; 2016.
   Google Scholar
• Veteran Beneficiaries, 2016. S.S. Administration, editor. USA: Office of Retirement Policy; 2017.
   Google Scholar
• Shaner A, Eckman TA, Roberts LJ, Wilkins JN, Tucker DE, Tsuang JW, Mintz J. Disability income, cocaine use, and repeated hospitalization among schizophrenic cocaine abusers — a government-sponsored revolving door? N Engl J Med. 1995;333:777–83. doi:10.1056/NEJM199509213331207.
   PubMed Web of Science ®Google Scholar
• Rosen MI. The ‘check effect’ reconsidered. Addiction. 2011;106:1071–77. doi:10.1111/j.1360-0443.2011.03409.x.
   PubMed Web of Science ®Google Scholar
• Swartz JA, Hsieh CM, Baumohl J. Disability payments, drug use and representative payees: an analysis of the relationships. Addiction. 2003;98:965–75. doi:10.1046/j.1360-0443.2003.00414.x.
   PubMed Web of Science ®Google Scholar
• Rosen MI, McMahon T, Lin H, Rosenheck R. Effect of social security payments on substance abuse in a homeless mentally ill cohort. Health Serv Res. 2006;41:173–91. doi:10.1111/j.1475-6773.2005.00481.x.
   PubMed Web of Science ®Google Scholar
• Li X, Sun H, Marsh DC, Anis AH. Impact of welfare cheque issue days on a service for those intoxicated in public. Harm Reduct J. 2007;4:12. doi:10.1186/1477-7517-4-12.
   PubMedGoogle Scholar
• Grossman LS, Willer, J K, Miller, N S, Stovall, J G, McRae, S G, Maxwell, S. Temporal patterns of veterans’ psychiatric service utilization, disability payments, and cocaine use. Journal of Psychoactive Drugs. 1997;29(3):285–90. doi:10.1080/02791072.1997.10400203.
   PubMed Web of Science ®Google Scholar
• Rosen MI, Rosenheck R, Ablondi K. ATM: a clinician manual to conduct money management with your clients.
   Google Scholar
• Conrad KJ, Conrad KJ, Matters MD, Luchins DJ, Hanrahan P, Quasius DL, Lutz G. Development of a money mismanagement measure and cross-validation due to suspected range restriction. J Appl Meas. 2006;7:206–24.
   PubMedGoogle Scholar
• Rosen MI, McMahon TJ, Rosenheck R. Does assigning a representative payee reduce substance abuse? Drug Alcohol Depend. 2007;86:115–22. doi:10.1016/j.drugalcdep.2006.05.026.
   PubMed Web of Science ®Google Scholar
• Ries RK, Dyck DG. Representative payee practices of community mental health centers in Washington state. Psychiatr Serv. 1997;48:811–4.
   PubMed Web of Science ®Google Scholar
• Conrad KJ, Lutz G, Matters MD, Donner L, Clark E, Lynch P. Randomized trial of psychiatric care with representative payeeship for persons with serious mental illness. Psychiatr Serv. 2006;57:197–204. doi:10.1176/appi.ps.57.2.197.
   PubMed Web of Science ®Google Scholar
• Luchins DJ, Hanrahan P, Conrad KJ, Savage C, Matters MD, Shinderman M. An agency-based representative payee program and improved community tenure of persons with mental illness. Psychiatr Serv. 1998;49:1218–22. doi:10.1176/ps.49.9.1218.
   PubMed Web of Science ®Google Scholar
• Trivedi AN, Jiang L, Miller DR, Swaminathan S, Johnson CA, Wu W-C, Greenberg K. Association of distability compensation with mortality and hospitalizations among vietnam-era Veterans with diabetes. JAMA Intern Med. 2022;182:757–765. doi:10.1001/jamainternmed.2022.2159.
   PubMed Web of Science ®Google Scholar
• Dixon L. Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes. Schizophr Res. 1999;35:S93–100. doi:10.1016/S0920-9964(98)00161-3.
   PubMed Web of Science ®Google Scholar
• Rosen MI, Desai R, Bailey M, Davidson L, Rosenheck R. Consumer experience with payeeship provided by a community mental health center. Psychiatr Rehabil J. 2001;25:190–5. doi:10.1037/h0095025.
   PubMed Web of Science ®Google Scholar
• What is dummy coding. OARC Stats. [accessed 2023 Aug 5. https://stats.oarc.ucla.edu/other/mult-pkg/faq/general/faqwhat-is-dummy-coding/#:-~:text.
   Google Scholar
• Kang H. The prevention and handling of the missing data. Korean J Anesthesiol. 2013;64:402–06. doi:10.4097/kjae.2013.64.5.402.
   PubMedGoogle Scholar
• The one sample T-Test. SAS Institute. [accessed 2023 Aug 5. https://sphweb.bumc.bu.edu/otit/mph-modules/bs/sas/sas4-onesampletttest/sas4-onesamplettest7.html.
   Google Scholar
• Nolte-Troha C, Roser P, Henkel D, Scherbaum N, Koller G, Franke AG. Uenmployment and substance use: an updated review of studies from North America and Europe. Healthcare. 2023;11:1182. doi:10.3390/healthcare11081182.
   Web of Science ®Google Scholar
• Nutt DJ, King LK, Phillips LD. Drug harms in the UK: a multicriteria decision analysis. Lancet. 2019;376:1558–65. doi:10.1016/S0140-6736(10)61462-6.
   Google Scholar
• van Amsterdam J, Nutt D, Phillips L, van den Brink W. European rating of drug harms. J Psychopharmacol. 2015;29:655–660. doi:10.1177/0269881115581980.
   PubMed Web of Science ®Google Scholar
• Johnson J, Byrne G, Pelecanos A. The prevalence of subthreshold psychiatric symptoms and associations with alcohol and substance use disorders: from a nationally representative survey of 36,309 adults. BMC Psychiatry. 2022;22:270. doi:10.1186/s12888-022-03834-1.
   PubMed Web of Science ®Google Scholar